Amgen Ventures
hybrid fundWebsite
Fund rating
0.0 / 35
0 published reviews
No per-dimension scores yet.
Published reviews
About
Evidence identifies Amgen Ventures as Amgen's corporate venture arm investing in biotechnology companies across early and later stages. OpenDrugs sits in biotech infrastructure and drug-discovery-enabling research, so this is a credible strategic capital target.